EZR and osteosarcoma: In conclusion, our observations demonstrated that adenovirus-mediated siRNA targetting ezrin can inhibit the proliferation, migration, and invasion of MG-63 cells, and induce apoptosis of MG-63 cells, which may be clinically helpful to cancer gene therapy for osteosarcoma treatment.